Given that the disruption of either Smyd3 or Shcbp1 could inhibit the tumor outgrowth, we hypothesized that SMYD3-SHCBP1 signaling might shape TIME benefiting tumor growth. This evidence concerns the gene SHCBP1 and neoplasm.